UNSPSC 51182051: Metenolone enantate

This classification denotes an anabolic agent with the molecular formula C27H42O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0SPD480WFH, chemically known as androst-1-en-3-one, 1-methyl-17-((1-oxoheptyl)oxy)-, (5.alpha.,17.beta.)-, but more generally known as metenolone enantate, which bears US NIH Compound Identifier 4089. European Medicines Agency schedules metenolone enantate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08823MIG.

Most nations, for tariff purposes, schedule metenolone enantate under HS 29372900. SMILES: CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C(=CC(=O)C4)C)C)C.

UNSPSC 51182051 Metenolone enantate is a Commodity code for a pharmaceutical active pharmaceutical ingredient (API) with no recent state and local contract opportunities on record.

The absence of solicitations under this code reflects its narrow scope — metenolone enantate is a controlled anabolic steroid used primarily in clinical settings for specific medical indications, not a commodity state or local governments routinely procure through open competition. State health departments, correctional agencies, and municipal health clinics that may require this substance do so through specialized pharmaceutical distribution channels, direct manufacturer contracts, or DEA-regulated procurement pathways that fall outside standard RFP and IFB processes. No issuing bodies, geographic regions, or representative opportunities are present in the available record.